Retinoic acid-induced differentiation in a human neuroblastoma cell line is associated with an increase in nitric oxide synthesis. 1998

D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
Department of Genetics, Biology and Medical Chemistry, University of Torino, Italy.

The human neuroblastoma cell line SK-N-BE, after incubation with 10 microM retinoic acid (RA) or 20 nM phorbol 12-myristate 13-acetate (PMA), underwent biochemical and morphological signs of differentiation within 10-14 days. In parallel, SK-N-BE cells produced significantly higher amounts of nitric oxide (NO) in comparison with controls, as assessed by the measurement of nitrite and nitrate in the culture supernatant and of NO synthase (NOS) activity in the cell lysates (measured as ability to convert [3H]arginine into [3H]citrulline and as NADPH diaphorase activity). Nitrite/nitrate production was abolished by adding the NO scavenger hemoglobin in the culture medium and was inhibited by aminoguanidine (AG, a selective inhibitor of the inducible NOS isoform) but not by the less selective inhibitor NG-nitro-L-arginine methylester (NAME). Western blotting experiments with monoclonal antibodies against the ncNOS and iNOS isoforms suggest that RA-elicited NOS activation is not attributable to an increased expression of the protein. NAME and AG were not able to revert inhibition of proliferation induced by RA, and the NO donor sodium nitroprusside did not mimic the effect of RA and PMA. These data indicate that increased NO synthesis does not mediate RA- or PMA-induced differentiation but may be an additional marker of differentiation into sympathetic-like neuronal cells.

UI MeSH Term Description Entries
D007641 Keratolytic Agents Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. Desquamating Agents,Skin-Peeling Agents,Agents, Desquamating,Agents, Keratolytic,Agents, Skin-Peeling,Skin Peeling Agents
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D019331 NG-Nitroarginine Methyl Ester A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension. L-NAME,N omega-Nitro-L-arginine Methyl Ester,NG-Nitro-L-Arginine Methyl Ester,N(G)-Nitro-L-arginine Methyl Ester,N(G)-Nitroarginine Methyl Ester,N(omega)-Nitro-L-arginine Methyl Ester,NG-Nitroarginine Methyl Ester, D-Orn-Isomer,NG-Nitroarginine Methyl Ester, L-Orn-Isomer, Monohydrochloride,Methyl Ester, NG-Nitro-L-Arginine,Methyl Ester, NG-Nitroarginine,N omega Nitro L arginine Methyl Ester,NG Nitro L Arginine Methyl Ester,NG Nitroarginine Methyl Ester,NG Nitroarginine Methyl Ester, D Orn Isomer

Related Publications

D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
April 1993, Brain research. Developmental brain research,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
January 2001, Medical and pediatric oncology,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
March 1996, Neuroreport,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
December 2003, Neuroscience letters,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
May 1992, Cancer letters,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
October 2015, Genetics and molecular research : GMR,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
June 1984, Cell differentiation,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
September 1992, Experimental cell research,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
April 1985, Neuroscience,
D Ghigo, and C Priotto, and D Migliorino, and D Geromin, and C Franchino, and R Todde, and C Costamagna, and G Pescarmona, and A Bosia
June 1987, Brain research,
Copied contents to your clipboard!